Abbott Labs Files 8-K on Shareholder Votes

Ticker: ABT · Form: 8-K · Filed: 2024-04-29T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: ABT

TL;DR

ABT filed an 8-K on shareholder votes as of 4/26. All standard corporate info.

AI Summary

Abbott Laboratories (ABT) filed an 8-K on April 29, 2024, reporting on matters submitted to a vote of security holders as of April 26, 2024. The filing details the company's principal executive offices and corporate information, including its state of incorporation (Illinois) and IRS identification number.

Why It Matters

This filing provides official notification of corporate actions and votes affecting Abbott Laboratories' security holders, which can impact governance and shareholder rights.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate information and shareholder votes, not indicating any immediate financial or operational risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Abbott Laboratories?

The primary purpose is to report on matters submitted to a vote of security holders as of April 26, 2024.

When was the earliest event reported in this filing?

The earliest event reported was on April 26, 2024.

What is Abbott Laboratories' state of incorporation?

Abbott Laboratories is incorporated in Illinois.

What is the ticker symbol for Abbott Laboratories?

The ticker symbol for Abbott Laboratories is ABT.

Where are Abbott Laboratories' principal executive offices located?

Abbott Laboratories' principal executive offices are located at 100 Abbott Park Road, Abbott Park, Illinois 60064-6400.

From the Filing

0001104659-24-054016.txt : 20240429 0001104659-24-054016.hdr.sgml : 20240429 20240429160805 ACCESSION NUMBER: 0001104659-24-054016 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240426 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24890682 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 8-K 1 tm2412877d1_8k.htm FORM 8-K false 0000001800 Common Shares, Without Par Value ABT 0000001800 2024-04-26 2024-04-26 0000001800 us-gaap:CommonStockMember exch:XCHI 2024-04-26 2024-04-26 0000001800 us-gaap:CommonStockMember exch:XNYS 2024-04-26 2024-04-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Common Shares, Without Par Value   ABT       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549       FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   April 26, 2024 Date of Report (Date of earliest event reported)     ABBOTT LABORATORIES (Exact name of registrant as specified in charter)       Illinois   1-2189   36-0698440 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)       100 Abbott Park Road Abbott Park , Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 224 ) 667-6100   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities Registered Pursuant to Section 12(b) of the Act:   Title of Each Class Trading Symbol(s) Name of Each Exchange  on Which Registered Common Shares, Without Par Value ABT New York Stock Exchange Chicago Stock Exchange, Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company   ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨             I tem 5.07 — Submission of Matters to a Vote of Security Holders.   Abbott held its Annual Meeting of Shareholders on April 26, 2024. The following is a summar

View on Read The Filing